Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-UMIN000003669
JPRN-UMIN000003669
Completed
N/A

Clinical research for hemoperfusion therapy with an immobilized polymyxin B (PMX) fiber column in patients with severe influenza pneumonia in Vietnam and Japan - Clinical research for hemoperfusion therapy in patients with severe influenza pneumonia

Disease Control and Prevention Center0 sites10 target enrollmentMay 27, 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionssevere influenza pneumonia

Overview

Phase
N/A
Intervention
Not specified
Conditions
severe influenza pneumonia
Sponsor
Disease Control and Prevention Center
Enrollment
10
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 27, 2010
End Date
March 31, 2014
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Disease Control and Prevention Center

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •(1\) Individuals who do not meet the above mentioned criteria for cases. (2\) Individuals who do not agree to sign the informed consents. (3\) Individuals with Immune deficiency. (4\) Individuals who are decided to be NOT suitable for this research by a clinical doctor.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
N/A
Hemoperfusion effect in treatment of patients with COVID-19
IRCT20110425006280N12Vice President of Research Guilan university of medical sciences20
Completed
Phase 2
Hemoperfusion in patients with COVID-19
IRCT20150704023055N2Babol University of Medical Sciences10
Recruiting
N/A
Efficacy of the Hemoperfusion Therapy in Patients with Severe COVID-19-Associated Pneumonia: An Experience from Single-center Observational StudySevere COVID-19-associated pneumonia with or without hemoperfusion therapyHemoperfusion, adsorption therapy, COVID-19, Pneumonia, Acute respiratory distress syndrome, Critical care, SARS-CoV2, cytokine storm, blood purification
TCTR20210627002Faculty of Medicine, Chiang Mai University15
Recruiting
Phase 2
Hemoperfusion in Covid 19
IRCT20210718051922N1Shahre-kord University of Medical Sciences60
Recruiting
Phase 2
The role of hemoperfusion in COVID-19COVID-19.COVID-19U07.1
IRCT20200608047686N2Shahid Beheshti University of Medical Sciences40